FBXL20: A Potential Drug Target Or Biomarker (G84961)

Target Name: FBXL20

NCBI ID: G84961

FBXL20

FBXL20: A Potential Drug Target Or Biomarker

FBXL20, also known as F-box and leucine rich repeat protein 20, is a protein that is expressed in various tissues throughout the body. It is a member of the F-box gene family, which is known for the presence of a specific protein domain called the F-box domain. This domain is known to be involved in various cellular processes, including protein-protein interactions and signaling pathways. FBXL20 is also known to contain a leucine rich repeat, which is a common structural motif that is found in various proteins.

Recent studies have suggested that FBXL20 may have potential as a drug target or biomarker. One reason for this is the fact that FBXL20 has been shown to play a role in various cellular processes that are related to cancer. For example, studies have shown that FBXL20 is highly expressed in various types of cancer, including breast, lung, and ovarian cancer. Additionally, experiments have shown that inhibiting FBXL20 can lead to a reduction in cancer cell proliferation and the formation of new blood vessels, which could be a potential mechanism for its anti-cancer effects.

Another potential reason for FBXL20's potential as a drug target is its role in the regulation of cellular processes that are important for overall cellular health. For example, FBXL20 has been shown to play a role in the regulation of cell adhesion, which is important for the proper functioning of tissues and organs. Additionally, FBXL20 has been shown to play a role in the regulation of cell signaling pathways, which are important for the regulation of cellular processes that are important for overall cellular health.

FBXL20 is also a potential biomarker for various diseases, including cancer. The presence of FBXL20 in various tissues and cells has been shown to be associated with the development and progression of various diseases, including cancer. Additionally, studies have shown that the levels of FBXL20 have been associated with the severity of certain diseases, such as heart disease and neurodegenerative diseases. This suggests that FBXL20 may be a useful biomarker for the diagnosis and treatment of these diseases.

In conclusion, FBXL20 is a protein that has been shown to play a role in various cellular processes that are important for overall cellular health. Its potential as a drug target or biomarker makes it an attractive target for further research. Further studies are needed to fully understand the role of FBXL20 in cellular processes and its potential as a drug or biomarker.

Protein Name: F-box And Leucine Rich Repeat Protein 20

Functions: Substrate-recognition component of the SCF (SKP1-CUL1-F-box protein)-type E3 ubiquitin ligase complex. Role in neural transmission (By similarity)

The "FBXL20 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FBXL20 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets